December 15, 2017December 15, 2017

Ocrevus’ Use Continues Rising, with RRMS Patients Receiving the Most Attention

News

U.S. neurologists are increasingly prescribing Genentech’s Ocrevus (ocrelizumab) to their multiple sclerosis patients, Spherix Global Insights reports. Another good sign for Genentech is that, in just three ... Read more

December 14, 2017December 18, 2017

Chronic and Neuropathic Pain in MS Patients Should Be Routinely Evaluated, Study Says

News

Multiple sclerosis patients should be routinely assessed for chronic and, especially, neuropathic pain in order to properly diagnose and treat this condition, which appears to directly ... Read more

December 14, 2017December 14, 2017

Body’s Biological Clock and Time of Day Affects Immune Cells, Mouse Study Shows

News

Researchers further explored how our internal biological clock — known as circadian rhythm — influences immune system responses. Disruptions to that rhythm are associated with immune diseases ... Read more

December 13, 2017December 17, 2017

Taurine Seen to Boost Effectiveness of MS Therapies in Remyelination Process, Study Shows

News

A natural metabolite called taurine may boost the effectiveness of existing multiple sclerosis (MS) therapies, researchers say. Taurine helps oligodendrocytes, which are cells responsible for myelin ... Read more

December 13, 2017December 13, 2017

Levels of Nerve Protein in Blood Provide Good Grasp of MS Activity, Study Finds

News

Blood levels of the nerve damage marker neurofilament light provide a reliable picture of multiple sclerosis activity in both the relapsing-remitting and progressive forms of the ... Read more

December 12, 2017December 14, 2017

Using Balloons to Increase Blood Flow from Brain Fails to Help MS Patients, Trial Finds

News

Using balloons to enlarge veins so that more blood flows out of the brain and spinal cord fails to help multiple sclerosis patients, according to a ... Read more

December 12, 2017December 14, 2017

Protamine, Anticoagulant Blocker, Seen to Aid Remyelination in Mice Within Limits

News

Protamine — an agent used to stop the anticoagulant effects of heparin — was seen to trigger remyelination in mice with myelin damage. But while pointing a ... Read more

December 11, 2017December 14, 2017

Australia Approves Shorter Mavenclad Treatment Regimen for Relapsing-Remitting MS

News

Australia has approved a shorter treatment regimen of Merck’s Mavenclad for relapsing-remitting multiple sclerosis. The Therapeutic Goods Administration authorized 20-day courses of the cladribine tablet form of the medication once ... Read more

December 11, 2017December 14, 2017

Diet Rich in Fruits, Veggies and Whole Grains May Slow MS Progression, Study Shows

News

A diet rich in vegetables, fruits and whole grains may decrease symptoms and lessen disease progression in patients with multiple sclerosis, a study suggests. Researchers enrolled 6,989 ... Read more

December 8, 2017December 14, 2017

Novartis’ Gilenya Improves Cognition, Reduces Relapses and MS Lesions, Phase 4 Trial Shows

News

Novartis’ Gilenya and interferon beta-1b-based therapies stop multiple sclerosis patients’ cognitive decline, a Phase 4 clinical trial shows. Gilenya also reduces patients’ relapses and the number of ... Read more

December 8, 2017December 14, 2017

Toyota Foundation and Nesta Launch $4 Million Global Challenge to Create ‘Smart’ Mobility Devices

News

Teams of inventors working to improve mobility for people with lower-limb paralysis, including those with multiple sclerosis (MS), are invited to take part in a $4 million technology challenge launched ... Read more

December 7, 2017December 14, 2017

Partners in Huge Cannabis Therapy Operation Planned for Australia Apply for Licenses

News

Two companies that plan a huge cannabis-growing and research facility in Australia have applied for licenses to run the operations, whose products could benefit multiple sclerosis patients. MYM ... Read more

December 7, 2017December 8, 2017

University of Illinois Researchers Win $300,000 Falk Award to Improve MS Drug Delivery

News

A research team at the University of Illinois College of Medicine has received $300,000 from the Falk Medical Research Trust to develop a novel drug delivery method that ... Read more

December 6, 2017December 7, 2017

National MS Society Endorses US-Canada Registry Aiming to Advance Research and Patient Care

News

The National Multiple Sclerosis Society has endorsed the North American Registry for Care and Research in Multiple Sclerosis, a collaborative effort involving other multiple sclerosis registries, ... Read more

December 6, 2017December 7, 2017

Health Canada Approves Merck’s Mavenclad to Treat RRMS

News

Canadians with relapsing-remitting multiple sclerosis can now receive Merck’s Mavenclad, now that Health Canada has approved Mavenclad as a therapy to reduce the frequency of MS exacerbations and delay ... Read more

December 5, 2017December 6, 2017

Human Vaccines Project Studies Aim to Unveil Workings of Immune System

News

Scientists announced positive and encouraging outcomes from two clinical studies — running as part of the larger Human Vaccines Project — aiming to unravel the mechanisms that ... Read more

December 5, 2017December 5, 2017

Laquinimod Fails to Slow Brain Atrophy and PPMS Progression, Says Developer Active Biotech

News

Sweden’s Active Biotech said its experimental therapy Laquinimod failed to meet the primary and secondary objectives of Phase 2 clinical trial evaluating the drug’s potential to treat primary progressive multiple sclerosis. Laquinimod, ... Read more

December 4, 2017December 14, 2017

Analysis Suggests Oral Steroids Better Than Intravenous Ones for Treating Relapsing MS

News

Oral steroids may be cheaper, more convenient and less invasive alternatives than intravenous steroids in treating relapses in multiple sclerosis (MS) patients, suggests an analysis of ... Read more